GlassScriptPhysician profile
Michael G Moront
NPI 1821091687
$543,414.70
in general payments reported to CMS, 2019-2025
24 companies · $40K in 2025
The $40K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128K · 2020: $50K · 2021: $91K · 2022: $79K · 2023: $50K · 2024: $106K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $99K · Consulting Fee: $45K · Honoraria: $20K · Travel and Lodging: $18K · Food and Beverage: $8,294 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,750 · Education: $42.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $98,880.00 |
| Consulting Fee | $45,407.79 |
| Honoraria | $19,500.00 |
| Travel and Lodging | $18,290.25 |
| Food and Beverage | $8,293.80 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,750.00 |
| Education | $42.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $176,829.88 | 2021-2025 | Avalus, Mosaic, Penditure |
| Atricure, INC. | $168,749.41 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $85,807.39 | 2019-2020 | |
| Haemonetics Corporation | $64,353.32 | 2020-2025 | Teg6s Hemostasis System, Teg5000 Hemostasis Analyzer |
| Artivion, INC. | $29,360.72 | 2023-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical |
| Edwards Lifesciences Corporation | $5,305.40 | 2019-2025 | Konect Resilia |
| Terumo Cardiovascular Systems Corporation | $5,000.00 | 2019-2020 | |
| Lsi Solutions INC | $3,369.74 | 2019-2025 | Cor-Knot, Cor Knot |
| Cardiva Medical, INC. | $2,250.00 | 2023 | Teg5000 Hemostasis Analyzer, Teg6s Hemostasis System |
| Abiomed | $1,056.89 | 2022-2025 | Impella |
| Biom'Up Sa | $1,000.00 | 2019 | |
| Baxter Healthcare | $63.90 | 2024 | Preveleak |
| Corcym INC | $50.25 | 2023 | Miami Instruments, Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Davol INC. | $40.17 | 2025 | Progel Applicator Spray Tips |
| Stryker Corporation | $28.78 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $27.79 | 2024 | |
| Karl Storz Endoscopy-America | $22.63 | 2020 | |
| Ethicon US, LLC | $20.40 | 2025 | Proximate, Echelon Flex |
| Hemosonics LLC | $20.08 | 2023 | Quantra Qplus System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.53 | 2022 | |
| Integra Lifesciences Corporation | $15.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.85 | 2019 | |
| Kls-Martin L.P. | $10.58 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moront listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.